Literature DB >> 2718825

Some physical characteristics of NIDA marijuana cigarettes.

L D Chait1, J Pierri.   

Abstract

Marijuana cigarettes of three different potencies (0.0%, 1.4% and 2.7% delta-9-tetrahydrocannabinol (THC) content) provided by the National Institute on Drug Abuse (NIDA) were compared on a variety of characteristics, including physical appearance, weight, burn rate, and deliveries of total particulate matter and carbon monoxide. Significant differences between the different potency cigarettes were obtained on most measures. These differences could be relevant to the design and interpretation of pharmacologic/toxicologic and behavioral studies conducted with these cigarettes. The possible basis for these observed differences, methods for minimizing some of them, and other potential problems related to the use of NIDA marijuana cigarettes are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2718825     DOI: 10.1016/0306-4603(89)90017-8

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  11 in total

1.  Cannabis is more than simply delta(9)-tetrahydrocannabinol.

Authors:  Ethan B Russo; John M McPartland
Journal:  Psychopharmacology (Berl)       Date:  2002-12-19       Impact factor: 4.530

2.  Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.

Authors:  Margaret Haney; Judith Rabkin; Erik Gunderson; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

3.  Urinary concentrations of PAH and VOC metabolites in marijuana users.

Authors:  Binnian Wei; K Udeni Alwis; Zheng Li; Lanqing Wang; Liza Valentin-Blasini; Connie S Sosnoff; Yang Xia; Kevin P Conway; Benjamin C Blount
Journal:  Environ Int       Date:  2015-12-12       Impact factor: 9.621

4.  Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.

Authors:  Margaret Haney; Divya Ramesh; Andrew Glass; Martina Pavlicova; Gillinder Bedi; Ziva D Cooper
Journal:  Neuropsychopharmacology       Date:  2015-04-16       Impact factor: 7.853

5.  Delta-9-tetrahydrocannabinol content and human marijuana self-administration.

Authors:  L D Chait
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana.

Authors:  Jane Metrik; Damaris J Rohsenow; Peter M Monti; John McGeary; Travis A R Cook; Harriet de Wit; Margaret Haney; Christopher W Kahler
Journal:  Exp Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.157

7.  Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.

Authors:  Frances R Levin; John J Mariani; Daniel J Brooks; Shan Xie; Kathleen A Murray
Journal:  Drug Alcohol Depend       Date:  2009-09-03       Impact factor: 4.492

8.  Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.

Authors:  L D Chait; J P Zacny
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.

Authors:  Margaret Haney; Robert J Malcolm; Shanna Babalonis; Paul A Nuzzo; Ziva D Cooper; Gillinder Bedi; Kevin M Gray; Aimee McRae-Clark; Michelle R Lofwall; Steven Sparenborg; Sharon L Walsh
Journal:  Neuropsychopharmacology       Date:  2015-12-28       Impact factor: 7.853

10.  Discriminative stimulus and subjective effects of smoked marijuana in humans.

Authors:  L D Chait; S M Evans; K A Grant; J B Kamien; C E Johanson; C R Schuster
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.